ID

43864

Description

Responsible Party: Association of Urogenital Oncology (AUO) ClinicalTrials.gov Identifier: NCT01717677 History of Changes Other Study ID Numbers: AP 65/11 DRKS00004405 ( Registry Identifier: Freiburger Register ) Study First Received: October 26, 2012 Last Updated: February 7, 2017 Evaluation of Four Treatment Modalities in Prostate Cancer With Low or "Early Intermediate" Risk (PREFERE) ODM derived from: https://clinicaltrials.gov/ct2/show/NCT01717677

Lien

https://clinicaltrials.gov/ct2/show/NCT01717677

Mots-clés

Versions (2)
  1. 26/06/2017 26/06/2017 -
  2. 20/09/2021 20/09/2021 -
Téléchargé le

20 septembre 2021

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Prostate Cancer DRKS00004405 NCT01717677 DRKS00004405

Anglais

Eligibility Prostate Cancer NCT01717677 DRKS00004405

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI-1
C1512693
Newly diagnosed, biopsy proven adenocarcinoma of the prostate (ultrasound guided biopsy by standardized protocol)
Description

Prostate Adenocarcinoma

Type de données

boolean

Alias
UMLS CUI [1]
C0007112
Men aged 18-75 years
Description

Gender and Age

Type de données

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
Recruitment within 3 months after histological confirmation
Description

Time of Recruitment

Type de données

boolean

Alias
UMLS CUI [1,1]
C2949735
UMLS CUI [1,2]
C0040223
Localized prostata cancer <= cT2a, NX or N0 M0
Description

TNM Prostate tumor staging

Type de données

text

Alias
UMLS CUI [1]
C0474935
PSA <= 10 ng / ml
Description

PSA

Type de données

boolean

Alias
UMLS CUI [1]
C0138741
Gleason score <= 7a (3 +4)
Description

Gleason Score

Type de données

boolean

Alias
UMLS CUI [1]
C0332326
ECOG performance status 0 or 1
Description

ECOG Performance Status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
<= 30% positive biopsy cores with largest contiguous tumor length <= 5 mm
Description

Prostate Biopsy

Type de données

boolean

Alias
UMLS CUI [1]
C0194804
IPSS score < 18
Description

IPSS score

Type de données

boolean

Alias
UMLS CUI [1]
C2827405
Urine flow (Qmax):> 15 ml / s
Description

Urine flow

Type de données

boolean

Alias
UMLS CUI [1]
C0232851
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI-1
C0680251
Unifocal Gleason 6 cancer <1mm
Description

Unifocal Gleason 6 cancer

Type de données

boolean

Alias
UMLS CUI [1]
C0332331
History of treatment for BPH e.g. TURP, HIFU or cryotherapy
Description

Treatment for BPH

Type de données

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C1704272
History of radiation therapy to the pelvis
Description

Pelvic radiotherapy

Type de données

boolean

Alias
UMLS CUI [1]
C0436276
Life expectancy <10 years
Description

Life expectancy

Type de données

boolean

Alias
UMLS CUI [1]
C0023671
ASA >= 4
Description

ASA

Type de données

boolean

Alias
UMLS CUI [1]
C1531480
Post-void residual urine > 50 ml
Description

Urinary Retention

Type de données

boolean

Alias
UMLS CUI [1]
C0080274
Prostate volume on transrectal ultrasound > 60 cm3
Description

Prostate volume

Type de données

boolean

Alias
UMLS CUI [1]
C1441416
Large median prostate lobe visualized on transrectal ultrasound
Description

Median prostate lobe

Type de données

boolean

Alias
UMLS CUI [1]
C0227972
Chronic intestinal inflammatory disease covering the rectum
Description

Inflammatory bowel disease

Type de données

boolean

Alias
UMLS CUI [1]
C0021390
Other active malignancy within the past 5 years (except for superficial basal cell carcinoma or non muscle infiltrating bladder carcinoma)
Description

Malignant Neoplasms

Type de données

boolean

Alias
UMLS CUI [1]
C0006826
Contraindications for prostatectomy, radiation therapy or Active Surveillance
Description

Contraindication

Type de données

boolean

Alias
UMLS CUI [1]
C0522473
Patients refusing written informed consent
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Retour au début de la page

Similar models

Eligibility Prostate Cancer NCT01717677 DRKS00004405

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
Prostate Adenocarcinoma
Item
Newly diagnosed, biopsy proven adenocarcinoma of the prostate (ultrasound guided biopsy by standardized protocol)
boolean
C0007112 (UMLS CUI [1])
Gender and Age
Item
Men aged 18-75 years
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Time of Recruitment
Item
Recruitment within 3 months after histological confirmation
boolean
C2949735 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
TNM Prostate tumor staging
Item
Localized prostata cancer <= cT2a, NX or N0 M0
text
C0474935 (UMLS CUI [1])
PSA
Item
PSA <= 10 ng / ml
boolean
C0138741 (UMLS CUI [1])
Gleason Score
Item
Gleason score <= 7a (3 +4)
boolean
C0332326 (UMLS CUI [1])
ECOG Performance Status
Item
ECOG performance status 0 or 1
boolean
C1520224 (UMLS CUI [1])
Prostate Biopsy
Item
<= 30% positive biopsy cores with largest contiguous tumor length <= 5 mm
boolean
C0194804 (UMLS CUI [1])
IPSS score
Item
IPSS score < 18
boolean
C2827405 (UMLS CUI [1])
Urine flow
Item
Urine flow (Qmax):> 15 ml / s
boolean
C0232851 (UMLS CUI [1])
Item Group
Exclusion Criteria
C0680251 (UMLS CUI-1)
Unifocal Gleason 6 cancer
Item
Unifocal Gleason 6 cancer <1mm
boolean
C0332331 (UMLS CUI [1])
Treatment for BPH
Item
History of treatment for BPH e.g. TURP, HIFU or cryotherapy
boolean
C0087111 (UMLS CUI [1,1])
C1704272 (UMLS CUI [1,2])
Pelvic radiotherapy
Item
History of radiation therapy to the pelvis
boolean
C0436276 (UMLS CUI [1])
Life expectancy
Item
Life expectancy <10 years
boolean
C0023671 (UMLS CUI [1])
ASA
Item
ASA >= 4
boolean
C1531480 (UMLS CUI [1])
Urinary Retention
Item
Post-void residual urine > 50 ml
boolean
C0080274 (UMLS CUI [1])
Prostate volume
Item
Prostate volume on transrectal ultrasound > 60 cm3
boolean
C1441416 (UMLS CUI [1])
Median prostate lobe
Item
Large median prostate lobe visualized on transrectal ultrasound
boolean
C0227972 (UMLS CUI [1])
Inflammatory bowel disease
Item
Chronic intestinal inflammatory disease covering the rectum
boolean
C0021390 (UMLS CUI [1])
Malignant Neoplasms
Item
Other active malignancy within the past 5 years (except for superficial basal cell carcinoma or non muscle infiltrating bladder carcinoma)
boolean
C0006826 (UMLS CUI [1])
Contraindication
Item
Contraindications for prostatectomy, radiation therapy or Active Surveillance
boolean
C0522473 (UMLS CUI [1])
Informed Consent
Item
Patients refusing written informed consent
boolean
C0021430 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial